This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Imperial College Innovations Limited, United Kingdom Research and Innovation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 173 
1 out of 77 
Years Active: 2026
Title: Innovations by Jesus Gil in Liver Disease Treatment
Introduction
Jesus Gil is an accomplished inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the treatment of liver diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Jesus Gil holds a patent titled "NMT Inhibitor Treatment of a Senescence-Associated Disease or Disorder of the Liver." This patent represents a breakthrough in the treatment of liver-related conditions, showcasing his dedication to improving patient outcomes through innovative solutions. He has 1 patent to his name.
Career Highlights
Throughout his career, Jesus has worked with notable organizations, including Imperial College Innovations Limited and United Kingdom Research and Innovation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable collaborators is Wouter Kallemeijn. Their partnership has fostered innovative ideas and advancements in the treatment of liver diseases.
Conclusion
Jesus Gil's work exemplifies the impact of innovation in healthcare. His patent and collaborations highlight his commitment to addressing significant medical challenges. His contributions are paving the way for future advancements in the treatment of liver diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile